MK0429

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0429, covering 2015-04-27 to 2015-04-27. Get the full timeline:

Most recent: Clinical Trial Update: MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011) [Phase 1]